iRhythm Technologies, Inc.
IRTC
NASDAQ·Healthcare·Medical - Devices·Mkt cap $4.0B
$123.07
▼ -0.29%
P/E
-286.21
Mkt Cap
$4.0B
52-Wk Range
$100.85–$212.00
52-Week Range
$100.85 - $212.00
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 34.2% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Wire-free, patch-based design superior to traditional Holter monitors
- Proprietary cloud analytics platform with AI-driven arrhythmia detection
- Strategic partnership with Verily Life Sciences for next-gen product development
- Established market presence and physician adoption in cardiac monitoring
Bear Case
1 risk
- Average volatility.
Growth
Stable outlook
Rising prevalence of atrial fibrillation and cardiac arrhythmias
Value
Deep value opportunity - significant discount to Medical Devices peers
Momentum
Strong
+13.8% over 3m
Quality
Excellent
Strong fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying IRTC right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Oct 29, 2026
AUG 6, 2026
Reported EPS of -$0.01 vs -$0.04 consensus (+75.0% surprise). Revenue of $224.2M vs $219.3M expected (+2.2%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+75.0%
Revenue trend · last 8Q
—
+24%
+20%
+26%
+31%
+27%
+26%
+20%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$147.5M
$164.3M
$158.7M
$186.7M
$192.9M
$208.9M
$199.4M
$224.2M
Margins · last 8Q
Gross
72.8%
Operating
-1.1%
Profit
-0.2%
Wall Street consensus
10 analysts · 90% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
90%
Hold
10%
Sell
0%
Median Price Target
—
Latest: Needham · Aug 7, 2026
vs Industry
How IRTC stacks vs Medical - Devices
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related